Namrata Bhatnagar

The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

Teeara Berry, William Luther, Namrata Bhatnagar et al. · Cancer Cell · 2012 · 327 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

Namrata Bhatnagar, Sathish K.R. Padi, Qi Zhang et al. · Cell Death and Disease · 2010 · 200 citations · Full text

Medicine, Cancer Biology, Oncology +17

ALK inhibitor resistance in ALKF1174L-driven neuroblastoma is associated with AXL activation and induction of EMT

David Debruyne, Namrata Bhatnagar, Bhawna Sharma et al. · Oncogene · 2015 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in <i>ALK</i>-mutated neuroblastoma

Nathan F. Moore, Anna M. Azarova, Namrata Bhatnagar et al. · Oncotarget · 2014 · 80 citations · Full text

Medicine, Oncology, Pharmacology +17

3,3′-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-Regulation of Survivin

Namrata Bhatnagar, Xia Li, Yue Chen et al. · Cancer Prevention Research · 2009 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17